Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07901491

SUVY VerSus SAccharose (SUVISA)

Conditions: Healthy Volunteers, Erythritol

Sex: All
Ages: 18 Years – 50 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 14
Sponsor: Minerais SAS

Location: Centre d'Investigation Clinique - CHU de Rennes - Hôpital Pontchaillou Rennes Ille-et-Vilaine

Summary

Sugar substitutes are increasingly used to reduce sugar intake. SÜVY is a food ingredient combining erythritol and polydextrose. This study compares the blood sugar response, insulin response, and platelet activity after drinking a solution of SÜVY (50 g) versus a solution of regular sugar (sucrose, 50 g) in 14 healthy adults. Each participant takes part in two visits separated by at least 7 days, receiving one product per visit in random order. The goal is to evaluate whether SÜVY produces a lower blood sugar response than sucrose, and whether it has any effect on blood clotting markers.

Eligibility Criteria

Inclusion Criteria: * Healthy adult volunteers aged 18 to 50 years * Body Mass Index (BMI) between 18.5 and 29.5 kg/m² * Fasting blood glucose \< 1.10 g/L * HbA1c \< 6.0% * Non-smoker * No known hemostatic disorder or thrombotic history * No antiplatelet, anticoagulant or NSAID medication within 10 days prior to each visit * Able to provide written informed consent Exclusion Criteria: * Diabetes mellitus (type 1 or type 2) or any antidiabetic treatment * Known intolerance to polyols or irritable bowel syndrome * Pregnancy or breastfeeding * Chronic inflammatory disease * Participation in another clinical study within 3 months prior to inclusion * Any condition that, in the investigator's judgment, would compromise the participant's safety or the integrity of the study data

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07901491). StuddyBuddy aggregates publicly available trial information.